Where Is Cannabis Legal In Europe? https://t.co/SlF9vGGSx5 https://t.co/2202HixZRq ...

Core Insights - Advanced Flower Capital Inc. (NASDAQ:AFCG) has transitioned from a real estate investment trust (REIT) to a business development company (BDC), enhancing long-term shareholder value by expanding investment options beyond real estate-backed loans [2] - In the latest quarter, the company reported a GAAP net loss of $12.5 million, equating to $0.57 per basic weighted average common share, while distributable earnings were $3.5 million, or $0.16 per share [3] - The company is addressing nonaccrual issues and increasing loan repayments, despite limited new funding in the cannabis market [3] Company Operations - Advanced Flower Capital Inc. specializes in commercial real estate financing services, focusing on developing, arranging, underwriting, and managing senior secured loans and other loan types for established businesses in the cannabis industry across various states [4]

Core Viewpoint - Innovative Industrial Properties (IIPR) has seen its shares decline over 60% from the peak in Q3 2024, but it offers a high dividend yield of 15.7%, raising questions about its potential recovery by 2026 [1]. Group 1: Positive Factors for Investors - Analysts project a slight revenue growth for Innovative Industrial Properties in 2026, with a consensus estimate of $269.7 million, representing a 1.5% increase from 2025, which is an improvement over recent revenue declines [3]. - The potential rescheduling of marijuana to Schedule III could benefit Innovative Industrial Properties by eliminating Section 280E of the tax code, allowing tenants to deduct standard business expenses, thereby improving their financial positions and ability to pay rents [4]. - The valuation of Innovative Industrial Properties may become more attractive in a favorable regulatory environment, trading at 11.4 times forward earnings, with some discounted cash flow models indicating its intrinsic value is significantly higher than the current share price [5]. Group 2: Risks and Considerations - Despite the potential for share price recovery in 2026, Innovative Industrial Properties remains a risky investment, as even minor underperformance could hinder revenue growth [6]. - Regulatory changes, while potentially beneficial, could also lead to increased competition for Innovative Industrial Properties if the SAFER Act is passed, allowing more banks to offer loans to cannabis operators, which may turn the company into a value trap [7].

New 2026 cannabis bills in Mississippi, Hawaii, and Nebraska reveal the next wave of drug testing challenges for employers. https://t.co/dQQGo9WAzJ ...

The United Center in Chicago. Think Chicago Bulls, Blackhawks, huge concerts. Well, they just said they're going to start selling THC drinks at events.I'm Brennon Gomez at CNBC with what could be a case study for cannabis in 2026. Imagine being at a concert and being able to order a cannabis margarita instead of a beer. This is actually the first major US arena to do this broadly, which is why people in the industry are watching it so closely.There's this big trend right now where people are drinking less a ...

Caribbean cannabis growers eye budding domestic sales and exports https://t.co/IKeLwMerPN ...

Core Viewpoint - The stock market experienced an unexpected decline following the White House's decision to reclassify marijuana as a less dangerous drug [1] Group 1 - The reclassification of marijuana is seen as a significant regulatory change that could impact the cannabis industry [1] - Investors reacted negatively to the news, leading to a drop in stock prices across various sectors [1] - The move may influence future legislation and market dynamics related to cannabis [1]

Legal & Regulatory Landscape - The US cannabis market is facing challenges due to conflicting state laws [1] - Rescheduling cannabis at the federal level is considered overdue [1]

Regulatory Changes & Political Landscape - The DEA is directed to reclassify cannabis from schedule 1 to schedule 3, easing restrictions on medical research, banking, and taxes [1] - A Medicare pilot program will allow some seniors to receive up to $500 per year in hemp-derived CBD products starting in April [2] - Congress passed a ban on all hemp products starting November 2026, including CBD products under the pilot program [2] - The White House will work with Congress to update the statutory definition of final hemp-derived cannabinoid products [3] Industry Dynamics & Lobbying - There has been growing industry engagement and intensified lobbying in Washington [3] - The president shared a medical CBD commercial produced by a longtime friend [4] - Cannabis's influence in DC has seen an uptick year-over-year [6] Strategic Considerations - The executive order is testing a limited medically focused path to reform [4] - The move is appealing to states already moving ahead and keeping tighter controls in place as the 2026 election cycle approaches [4] - The president may see this as appealing to younger and senior voters as the 2026 midterm election process approaches [6]

Cannabis Industry - A new era for cannabis as Trump reclassifies marijuana [1] Business & Finance - TikTok's agreement with American investors [1] - Slower inflation [1] - Trump Media's nuclear fusion deal [1] Other - Mentions of a private defense billionaire [1]